For the correlation analysis of MAP in the EGCG group, positive correlations with BW, BMI, and fat mass increased from non-significant to statistically significant from before to after 8 weeks of treatment, while the correlation with serum adiponectin levels decreased from significant to non-significant, indicating a shift towards stronger correlations with obesity parameters and weaker correlations with hormones involved in insulin sensitivity after treatment, similar to SBP. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.